Identity of adenylyl cyclase isoform determines the G protein mediating chronic opioid-induced adenylyl cyclase supersensitivity

Journal of Neurochemistry

Volumn 83, Issue 4, 2002, Pages 818-827

  Ammer, Hermann ^a   Christ, Thomas E ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Adenylyl cyclase; Gz ; Morphine; Opioid receptor; Supersensitivity; Tolerance dependence

Indexed keywords

ADENYLATE CYCLASE; CYCLIC AMP; GUANINE NUCLEOTIDE BINDING PROTEIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; ISOENZYME; MORPHINE; MU OPIATE RECEPTOR; OPIATE; PERTUSSIS TOXIN;

ANIMAL CELL; ARTICLE; CELL STRAIN COS7; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG TOLERANCE; DRUG WITHDRAWAL; NONHUMAN; OPIATE ADDICTION; PRECIPITATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ADENYLATE CYCLASE; ANIMALS; COS CELLS; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOLERANCE; ENZYME ACTIVATION; FORSKOLIN; GTP-BINDING PROTEIN ALPHA SUBUNITS; GTP-BINDING PROTEINS; HETEROTRIMERIC GTP-BINDING PROTEINS; HUMANS; ISOENZYMES; KIDNEY; MORPHINE; NARCOTICS; PROTEIN BINDING; RECEPTORS, OPIOID, MU; SIGNAL TRANSDUCTION; SUBSTANCE-RELATED DISORDERS; TIME; TRANSFECTION;

ANIMALIA;

EID: 0036847009     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2002.01188.x     Document Type: Article

References (42)

1. Ammer H. and Schulz R. (1993) Alterations in the expression of G-proteins and regulation of adenylate cyclase in human neuro- blastoma SH-SY5Y cells chronically exposed to low-efficacy μ-opioids. Biochem. J. 295, 263-271.
2. 1 receptor system in neuroblastoma x glioma (NG108-15) hybrid cells. J. Neurochem. 64, 2449-2457.
3. Ammer H. and Schulz R. (1997) Chronic morphine treatment increases stimulatory β-adrenoceptor signaling in A431 cells stably expressing the mu opioid receptor. J. Pharmacol. Exp. Ther. 280, 512-520.
4. Avidor-Reiss T, Nevo I., Levy R., Pfeuffer T. and Vogel Z. (1996) Chronic opioid treatment induces adenylyl cyclase V superactivation. Involvement of Gβγ. J. Biol. Chem. 271, 21309-21315.
5. Avidor-Reiss T., Nevo I., Saya D., Bayewitch M. and Vogel Z. (1997) Opiate-induced adenylyl cyclase superactivation is isozyme- specific. J. Biol. Chem. 272, 5040-5047.
6. Chen Y., Mestek A., Liu J., Hurley J. A. and Yu L. (1993) Molecular cloning and functional expression of a mu-opioid receptor from rat brain. Mol. Pharmacol. 44, 8-12.
7. Collier H. O. J. (1984) Cellular aspects of opiate tolerance and dependence, in: Opioids: Past, Present and Future (Hughes J., Collier H. O. J., Rance M. J. and Tyres M. B., eds), pp. 109-125. Taylor & Francis Ltd, London.
8. iα binding site on type V adenylyl cyclase. J. Biol. Chem. 273, 25831-25839.
9. zα by protein kinase C blocks interaction with the βγ complex. J. Biol. Chem. 270, 23119-23125.
10. Gudermann T., Kalkbrenner F. and Schultz G. (1992) Diversity and selectivity of receptor-G protein interaction. Annu. Rev. Pharmacol. Toxicol. 36, 429-459.
11. zα, in neurons of brain and retina. J. Neurosci. 10, 2763-2770.
12. Iwami G., Kawabe J., Ebina T., Cannon P. J., Homcy C. J. and Ishikawa Y. (1995) Regulation of adenylyl cyclase by protein kinase A. J. Biol. Chem. 270, 12481-12484.
13. Kawabe J., Iwami G., Ebina T., Ohno S., Katada T., Ueda Y., Homcy C. J. and Ishikawa Y. (1994) Differential activation of adenylyl cyclase by protein kinase C isoenzymes. J. Biol. Chem. 269, 16554-16558.
14. Kleuss C., Hescheler J., Ewel C., Rosenthal W., Schultz G. and Wittig B. (1991) Assignment of G-protein subtypes to specific receptors inducing inhibition of calcium currents. Nature 353, 43-48.
15. z. J. Biol. Chem. 270, 1734-1741.
16. Krupinski J., Lehman T. C., Frankenfield C. D., Zwaagstra J. C. and Watson P. A. (1992) Molecular diversity in the adenylylcyclase family. Evidence for eight forms of the enzyme and cloning of type VI. J. Biol. Chem. 267, 24858-24862.
17. Laugwitz K. L., Offermanns S., Spicher K. and Schultz G. (1993) μ and δ opioid receptors differentially couple to G protein subtypes in membranes of human neuroblastoma SH-SY5Y cells. Neuron 10, 233-242.
18. (+) channels. J. Biol. Chem. 275, 921-929.
19. zα by site-directed mutagenesis. Sites and specificity of protein kinase C-dependent phosphorylation. J. Biol. Chem. 268, 3494-3498.
20. Lux B. and Schulz R. (1986) Effect of cholera toxin and pertussis toxin on opioid tolerance and dependence in the guinea-pig myenteric plexus. J. Pharmacol. Exp. Ther 237, 995-1000.
21. Mons N., Harry A., Dubourg P., Premont R. T., Iyengar R. and Cooper D. M. (1995) Immunohistochemical localization of adenylyl cyclase in rat brain indicates a highly selective concentration at synapses. Proc. Natl Acad. Sci. USA 92, 8473-8477.
22. sα. Biochemistry 29, 9079-9084.
23. i2. Am. J. Physiol. Cell. Physiol. 279, C925-C934.
24. Neer E. J. (1995) Heterotrimeric G proteins: Organizers of transmembrane signals. Cell 80, 249-257.
25. Nestler E. J. and Aghajanian G. K. (1997) Molecular and cellular basis of addiction. Science 278, 58-63.
26. z, a PTX-insensitive G protein. Neurosci. Lett. 267, 117-120.
27. Premont R. T. (1994) Identification of adenylyl cyclases by amplification using degenerate primers. Methods Enzymol. 238, 116-127.
28. Roerig S. C., Loh H. H. and Law P. Y. (1992) Identification of three separate guanine nucleotide-binding proteins that interact with the delta-opioid receptor in NG108-15 neuroblastoma x glioma hybrid cells. Mol. Pharmacol. 41, 822-831.
29. Sanchez-Blazquez P., Gomez-Serranillos P. and Garzon J. (2001) Agonists determine the pattern of G-protein activation in mu-opioid receptor-mediated supraspinal analgesia. Brain Res. Bull. 54, 229-235.
30. Sharma S. K., Klee W. A. and Nirenberg M. (1975) Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. Proc. Natl Acad Sci. USA 8, 3092-3096.
31. α C-terminal antibodies. Proc. Natl Acad. Sci. USA 86, 7809-7813.
32. Sunahara R. K., Dessauer C. W. and Gilman A. G. (1996) Complexity and diversity of mammalian adenylyl cyclases. Annu. Rev. Pharmacol. Toxicol. 36, 461-480.
33. Tang W. J., Krupinski J. and Gilman A. G. (1991) Expression and characterization of calmodulin-activated (type I) adenylylcyclase. J. Biol. Chem. 266, 8595-8603.
34. Taussig R. and Gilman A. G. (1995) Mammalian membrane-bound adenylyl cyclases. J. Biol. Chem. 270, 1-4.
35. Taussig R., Tang W. J., Hepler J. R. and Gilman A. G. (1994) Distinct patterns of bidirectional regulation of mammalian adenylyl cyc-lases. J. Biol. Chem. 269, 6093-6100.
36. Thomas J. M. and Hoffman B. B. (1992) Adaptive increase in adenylyl cyclase activity in NG108-15 and S49 cells induced by chronic treatment with inhibitory drugs is not due to a decrease in cyclic AMP concentrations. Cell. Signal. 4, 417-428.
37. Thomas J. M. and Hoffman B. B. (1996) Isoform-specific sensitization of adenylyl cyclase activity by prior activation of inhibitory receptors: Role of βγ subunits in transducing enhanced activity of the type VI isoform. Mol. Pharmacol. 49, 907-914.
38. z can mediate the acute actions of μ- and κ-opioids but is not involved in opioid-induced adenylyl cyclase supersensitization. J. Pharmacol. Exp. Ther. 295, 168-176.
39. Wallach J., Droste M., Kluxen F. W., Pfeuffer T. and Frank R. (1994) Molecular cloning and expression of a novel type V adenylyl cyclase from rabbit myocardium. FEBS Lett. 338, 257-263.
40. Williams A. G., Woolkalis M. J., Poncz M., Manning D. R., Gewirtz A. M. and Brass L. F. (1990) Identification of the pertussis toxin-sensitive G proteins in platelets, megakaryocytes, and human erythroleukemia cells. Blood 76, 721-730.
41. Williams J. T., Christie M. J. and Manzoni O. (2001) Cellular and synaptic adaptations mediating opioid dependence. Physiol. Rev. 81, 299-343.
42. z-mediated hormonal inhibition of cyclic AMP accumulation. Science 255, 339-342.